These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27177665)

  • 1. Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.
    Phan MT; Lee SH; Kim SK; Cho D
    Methods Mol Biol; 2016; 1441():167-74. PubMed ID: 27177665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.
    Baek HJ; Kim JS; Yoon M; Lee JJ; Shin MG; Ryang DW; Kook H; Kim SK; Cho D
    Anticancer Res; 2013 May; 33(5):2011-9. PubMed ID: 23645750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
    Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
    Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex Vivo Expansion of Human NK Cells Using K562 Engineered to Express Membrane Bound IL21.
    Somanchi SS; Lee DA
    Methods Mol Biol; 2016; 1441():175-93. PubMed ID: 27177666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expansion of human natural killer cells ex vivo].
    Huang QS; Li Q; Huang Y; Shang P; Zhang MJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1167-9. PubMed ID: 19068202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21.
    Kweon S; Phan MT; Chun S; Yu H; Kim J; Kim S; Lee J; Ali AK; Lee SH; Kim SK; Doh J; Cho D
    Front Immunol; 2019; 10():879. PubMed ID: 31105701
    [No Abstract]   [Full Text] [Related]  

  • 8. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray as Irradiation Alternative for K562 Feeder Cell Inactivation in Human Natural Killer Cell Expansion.
    Kim GH; Dang HN; Phan MT; Kweon SH; Chun S; Cho D
    Anticancer Res; 2018 Oct; 38(10):5767-5772. PubMed ID: 30275198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15.
    Gong W; Xiao W; Hu M; Weng X; Qian L; Pan X; Ji M
    Tissue Antigens; 2010 Dec; 76(6):467-75. PubMed ID: 20670353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Modification of Human Natural Killer Cells Using a Retroviral Vector.
    Kellner JN; Cruz CR; Bollard CM; Yvon ES
    Methods Mol Biol; 2016; 1441():203-13. PubMed ID: 27177668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.
    Lee DY; Kim Y; Park JS; Choi JU; Jeong HG; Park CH
    Anticancer Res; 2023 Sep; 43(9):3897-3904. PubMed ID: 37648291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
    Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS
    Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
    Thangaraj JL; Phan MT; Kweon S; Kim J; Lee JM; Hwang I; Park J; Doh J; Lee SH; Vo MC; Chu TH; Song GY; Ahn SY; Jung SH; Kim HJ; Cho D; Lee JJ
    Cancer Immunol Immunother; 2022 Mar; 71(3):613-625. PubMed ID: 34282497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
    Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
    Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
    Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.
    Lapteva N; Durett AG; Sun J; Rollins LA; Huye LL; Fang J; Dandekar V; Mei Z; Jackson K; Vera J; Ando J; Ngo MC; Coustan-Smith E; Campana D; Szmania S; Garg T; Moreno-Bost A; Vanrhee F; Gee AP; Rooney CM
    Cytotherapy; 2012 Oct; 14(9):1131-43. PubMed ID: 22900959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
    Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
    Masuyama J; Murakami T; Iwamoto S; Fujita S
    Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.